Source comparison
TB-500 Fibrosis Reduction Research: Study Design Comparison
Understanding how different research protocols compare helps contextualize conflicting results and identify optimal intervention windows for future investigation. Cardiac MI (coronary ligation) 6 mg/kg IP, 3×/week 24h post-injury Fibrotic area by trichrome 42%
This comparison does not assign a generated winner or score.
- Understanding how different research protocols compare helps contextualize conflicting results and identify optimal intervention windows for future investigation.
- Cardiac
- MI (coronary ligation)
- 6 mg/kg IP, 3×/week
- 24h post-injury
- Fibrotic area by trichrome
- 42% reduction
- Early intervention produced strongest effect; delayed start (>7 days) showed minimal benefit
- Hepatic
- CCl₄-induced cirrhosis
- 5 mg/kg SC, 2×/week
- Mid-stage (week 4 of 8)
- Hydroxyproline content
- 34% reduction
- Intervention during active injury more effective than post-injury administration
- Pulmonary
- Bleomycin-induced
- 10 mg/kg SC, daily
- Day 7 post-challenge
- Ashcroft score + hydroxyproline
- 28–41% reduction (measure-dependent)
- Dose-response confirmed; highest dose approached but didn't normalize tissue architecture
- Renal
- UUO (obstruction)
- 7.5 mg/kg SC, 3×/week
- Immediate post-obstruction
- Interstitial fibrosis %
- 41% reduction
- Significant improvement but incomplete reversal; chronic obstruction may exceed peptide capacity
- Dermal
- Excisional wound
- 2 mg/kg SC, daily
- Immediate post-injury
- Scar width & tensile strength
- 31% scar area reduction, 18% strength increase
- Cosmetic improvement without compromising mechanical healing. Rare outcome